Navin Sewak

Navin Sewak serves as the Global Market Access Director for Early Development at ViiV Healthcare, leading global access strategies for early development assets related to HIV treatment, prevention, and cure since June 2021. In addition, Navin is an active member of PSPA, contributing as a Patient Involvement Member, Volunteer Policy Advisor, and Research Committee Lay Member. Prior experience includes various roles at Pfizer from 2015 to 2021, where Navin focused on payer insights, access strategies, and real-world data. Earlier roles include consultancy at Double Helix Consulting, membership on the NICE Technology Appraisal Committee, and positions within the NHS and academic institutions, focusing on health economics and pharmacy education. Navin is currently pursuing an Executive MBA at Imperial Business School and holds an Economic Evaluation in Healthcare degree from City, St George’s, University of London.